Additionally, we report a method for PD-L1 staining of Parsortix-enriched CTCs and show that the PD-L1 status of CTCs does not correlate with the PD-L1 TPS, thus indicating considerable heterogeneity between the primary tumor and CTCs (Figure 4). This evidence concerns the gene CD274 and neoplasm.